Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

doxorubicin-loaded 1,2-bis(10,12-tricosadiynoyl)-sn-glycero-3-phosphoethanol-amine-modified poly(3,9-bis(3-aminopropyl)-2,4,8,10-tetraoxaspiro[5.5]-undecane-isophorone diisocyanate) micelles

Based on

1 Articles
2016 Most recent source

Composition

1

1,2-bis(10,12-tricosadiynoyl)-sn-glycero-3-phosphoethanol-amine-modified poly(3,9-bis(3-aminopropyl)-2,4,8,10-tetraoxaspiro[5.5]-undecane-isophorone diisocyanate)

DCPE-modified poly(ATU-IPDI) DCPE-PU-DCPE
Type Polymer
Formula
Role carriers
2

adriblastin

adriblastin adriamycin DOX DXR
Type Single Compound
Formula C27H29NO11
Role loaded material

Properties

Applications

Area Application Source
medicine/veterinary

0 more entry available to subscribers only.

Or, view sample content

Characterization

Method Source
dynamic light scattering

0 more entry available to subscribers only.

Or, view sample content

Biological effects

Preparation

Method 1

Type: Physical formation
Source:
Product

doxorubicin-loaded 1,2-bis(10,12-tricosadiynoyl)-sn-glycero-3-phosphoethanol-amine-modified poly(3,9-bis(3-aminopropyl)-2,4,8,10-tetraoxaspiro[5.5]-undecane-isophorone diisocyanate) micelles

Method 2

Type: Physical formation
Source:
Product

doxorubicin-loaded 1,2-bis(10,12-tricosadiynoyl)-sn-glycero-3-phosphoethanol-amine-modified poly(3,9-bis(3-aminopropyl)-2,4,8,10-tetraoxaspiro[5.5]-undecane-isophorone diisocyanate) micelles

Method 3

Type: Physical formation
Source:
Product

doxorubicin-loaded 1,2-bis(10,12-tricosadiynoyl)-sn-glycero-3-phosphoethanol-amine-modified poly(3,9-bis(3-aminopropyl)-2,4,8,10-tetraoxaspiro[5.5]-undecane-isophorone diisocyanate) micelles

Method 4

Type: Physical formation
Source:
Product

doxorubicin-loaded 1,2-bis(10,12-tricosadiynoyl)-sn-glycero-3-phosphoethanol-amine-modified poly(3,9-bis(3-aminopropyl)-2,4,8,10-tetraoxaspiro[5.5]-undecane-isophorone diisocyanate) micelles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial